Cleviprex is a Intravenous Emulsion in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Austria Gmbh. The primary component is Clevidipine.
Product ID | 18124-011_0ef540ec-3e55-44d0-b8b9-e70407a54748 |
NDC | 18124-011 |
Product Type | Human Prescription Drug |
Proprietary Name | Cleviprex |
Generic Name | Clevidipine |
Dosage Form | Emulsion |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2008-09-15 |
Marketing Category | NDA / NDA |
Application Number | NDA022156 |
Labeler Name | Fresenius Kabi Austria GmbH |
Substance Name | CLEVIDIPINE |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2008-09-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022156 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-09-15 |
Marketing Category | NDA |
Application Number | NDA022156 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-09-15 |
Marketing Category | NDA |
Application Number | NDA022156 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-09-15 |
Ingredient | Strength |
---|---|
CLEVIDIPINE | .5 mg/mL |
SPL SET ID: | a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
10122-610 | Cleviprex | clevipidine |
10122-611 | Cleviprex | clevipidine |
10122-612 | Cleviprex | clevipidine |
18124-011 | Cleviprex | clevidipine |
65293-005 | Cleviprex | clevidipine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CLEVIPREX 90349617 not registered Live/Pending |
CHIESI FARMACEUTICI S.P.A. 2020-11-30 |
CLEVIPREX 87442641 not registered Live/Pending |
Chiesi Farmaceutici S.P.A. 2017-05-09 |
CLEVIPREX 77032009 3540746 Live/Registered |
CHIESI FARMACEUTICI S.P.A. 2006-10-30 |